Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial

Eun Jung Jun,Eun-Seok Shin,Song Lin Yuan,Youngjune Bhak,Scot Garg,Woong Chol Kang,Je Sang Kim,June-Hong Kim,Jang-Whan Bae,Seung-Woon Rha,In-Ho Chae

JACC: Asia（2022）

引用 1|浏览2

暂无评分

摘要

In this multicenter, head-to-head comparison randomized trial, the novel shellac plus vitamin E-based DCB showed a comparable result to the reference iopromide-based device for the primary endpoint of 6-month in-segment LLL for the treatment of coronary ISR. (Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patient With Coronary In-stent Restenosis; NCT04405063).

查看译文

关键词

cardiovascular events,drug-coated balloon,in-segment late lumen loss,major adverse

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要